ArticleOncoimmunology2022
MHC class II molecules on pancreatic cancer cells indicate a potential for neo-antigen-based immunotherapy.
Renato B Baleeiro et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
23 papers cite it
this papercites it